2020-12-17,Viveve Regains Compliance with NASDAQ Continued Listing Rules
2020-12-10,Viveve Announces FDA Approval of Proposed Amendments to Pivotal U.S. PURSUIT Trial Protocol
2020-12-03,Viveve Announces FDA 510K Approval to Expand Manufacturing of Treatment Tips
2020-12-02,Return On Capital Employed Overview: Viveve Medical
2020-11-12,Viveve Reports Third Quarter 2020 Financial Results and Provides Corporate Update
2020-11-12,"Viveve Medical, Inc. to Host Earnings Call"
2020-11-10,Viveve to Participate in Alliance Group Partners Virtual Healthcare Symposium
2020-11-05,"Viveve to Host Conference Call on November 12, 2020 to Report Third Quarter Financial Results and Provide Corporate Update"
2020-10-30,Viveve Appoints New Independent Board Director
2020-10-27,Viveve Launches New Clinical Advisory Board in Urinary Incontinence
2020-09-22,Viveve Announces Issuance of Novel U.S. Method Patent for Stress Urinary Incontinence
2020-09-03,Viveve to Present at H.C. Wainwright 22nd Annual Global Investment Conference
2020-09-01,Viveve Announces Exercise of Warrants for $3.6 Million
2020-08-31,Overview Of Value Stocks In The Healthcare Sector
2020-08-25,"The Daily Biotech Pulse: Altimmune Reports Positive Preclinical Data For Intranasal COVID-19 Vaccine, AbbVie Licenses Morphic's Drug, Viveve Clinical Readout"
2020-08-25,Viveve Announces Positive Primary Efficacy Data from its SUI Feasibility Study and Positive Preclinical Outcomes that Support the Companys New Sham Tip for Pivotal PURSUIT Trial
2020-08-13,Viveve Reports Second Quarter 2020 Financial Results and Provides Corporate Update
2020-08-06,"Viveve to Host Conference Call on August 13, 2020 to Report Second Quarter 2020 Financial Results and Provide Corporate Update"
2020-07-14,Viveve Announces Clearance of Viveve 2.0 System in Thailand
2020-07-07,Viveve Announces FDA Approval to Conduct PURSUIT Trial for Improvement of Stress Urinary Incontinence
2020-06-29,Viveve Medical Announces Adjournment of Annual Meeting
2020-05-29,Heres why Tipiak Société Anonymes (EPA:TIPI) Returns On Capital Matters So Much
2020-05-14,Viveve Reports First Quarter 2020 Financial Results and Provides Corporate Update
2020-05-07,"Viveve to Host Conference Call to Provide Corporate Update and First Quarter 2020 Financial Results on May 14, 2020"
2020-04-17,Viveve Announces Update to Corporate Strategy
2020-04-17,Viveve Announces Exercise of Warrants for $3 Million Gross Proceeds
2020-04-16,Viveve Announces Approval of Viveve 2.0 System in Canada
2020-04-15,Viveve Resubmits U.S. Investigational Device Exemption to FDA to Conduct New PURSUIT Trial for Improvement of Stress Urinary Incontinence
2020-04-09,Viveve Announces Topline Results from Pivotal U.S. VIVEVE II Trial for Improvement of Sexual Function in Women
2020-03-26,Edited Transcript of VIVE earnings conference call or presentation 19-Mar-20 9:00pm GMT
2020-03-26,American Medical Association President Discusses COVID-19 Pandemic Affect on Doctors
2020-03-26,Viveve Announces Clearance of Next Generation 2.0 System in Taiwan
2020-03-19,Viveve Reports Full Year 2019 Financial Results
2020-03-19,"Viveve Medical, Inc. to Host Earnings Call"
2020-03-12,Viveve Announces Completion of VIVEVE II Pivotal FDA Clinical Trial for Improvement of Sexual Function
2020-03-06,"Viveve to Host Conference Call to Provide Corporate Update and Year-End 2019 Financial Results on March 19, 2020"
2020-03-04,Viveve Completes Enrollment in Short-Term Feasibility Study for Stress Urinary Incontinence
2020-02-19,"Benzinga Pro's Top 5 Stocks To Watch For Wed., Feb. 19, 2020: BLPH, GRPN, VIVE, CODX, GNPX"
2020-01-22,"Company News for Jan 22, 2020"
2020-01-14,Viveve Initiates Enrollment of its Short-Term Feasibility Study in Stress Urinary Incontinence
2020-01-02,"Company News For Jan 2, 2020"
2019-12-31,Viveve Announces Compliance with Nasdaq Listing Rules
2019-12-18,Viveve Announces Authorization to Initiate Short-Term Feasibility Study in Stress Urinary Incontinence from Canadian Ministry of Health
2019-12-10,Viveve Announces Clearance of Next Generation 2.0 System in South Korea
2019-12-03,Viveve Announces Launch of Viveve 2.0 System in China
2019-11-26,Viveve Announces Closing of $11.5 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option
2019-11-26,Edited Transcript of VIVE earnings conference call or presentation 7-Nov-19 10:00pm GMT
2019-11-22,Viveve Announces Pricing of $10 Million Underwritten Public Offering
2019-11-07,Viveve Reports Third Quarter 2019 Financial Results and Provides Corporate Update
2019-11-07,"The Daily Biotech Pulse: Obseva Sinks On Adverse Clinical Readout, BioNano Surges On Saphyr Adoption, 2 IPOs"
2019-10-24,"Viveve to Host Conference Call to Provide Corporate Update and Third Quarter 2019 Results on November 7, 2019"
2019-10-11,Viveve Medical stock plunges toward record low after filing to sell more shares
2019-10-04,Waiting For October
2019-10-01,"A Look At Benzinga Pro's Most-Searched Tickers For October 1, 2019"
2019-10-01,Viveve Raises $6.76 million Through Completion of At-The-Market Equity Financing
2019-09-19,Viveve Submits Investigational Testing Application to Conduct Short-Term Feasibility Study in Stress Urinary Incontinence
2019-09-18,Viveve and its New CEO are Pioneering Women's Intimate Health
2019-09-18,Viveve Announces Reverse Stock Split to Regain NASDAQ Compliance
2019-09-17,Viveve to Present at the Ladenburg Thalmann 2019 Healthcare Conference
2019-09-05,Edited Transcript of VIVE earnings conference call or presentation 8-Aug-19 8:30pm GMT
2019-09-03,Viveve to Present at the H.C. Wainwright 21st Annual Global Investment Conference
2019-09-03,"Viveve Signs Exclusive Distribution Partnership with Paragon Meditech in Hong Kong, China and Macau"
2019-08-22,Viveve Signs Exclusive Distribution Partnership in Canada with Salient Medical Solutions
2019-08-08,Viveve Reports Second Quarter 2019 Financial Results and Provides Corporate Update
2019-08-07,Viveve Reports Additional Clinical Results of LIBERATE-International Trial for Stress Urinary Incontinence
2019-08-01,"Viveve to Host Conference Call to Provide Corporate Update and Second Quarter 2019 Results on August 8, 2019"
2019-07-23,"The Daily Biotech Pulse: Acadia Schizophrenia Drug Fails, Viveve Plummets, Eisai Gets Breakthrough Therapy Designation"
2019-07-22,"Viveve Announces Top-line Results of LIBERATE-International Trial for SUI, Q2 Transition to New U.S. Commercial Model, and Pursuit of Financial and Strategic Alternatives"
2019-06-25,Viveve Announces FDA 510(k) Clearance of Viveve 2.0 Next Generation System in the U.S.
2019-06-13,Edited Transcript of VIVE earnings conference call or presentation 9-May-19 9:00pm GMT
2019-06-11,Viveve to Present at Raymond James Life Sciences and MedTech Conference
2019-05-30,Penny Stocks to Buy Using Technical Analysis for June 2019
2019-05-24,VIVE: Q1 Results: Restructuring Dramatically Improves Op Loss. $20M Sales Guidance Intact. SUI Data Read-Out This Summer
2019-05-09,Viveve Reports First Quarter 2019 Financial and Operating Results
2019-05-02,"Viveve to Host Conference Call to Discuss First Quarter 2019 Financial and Operating Results on May 9, 2019"
2019-04-12,"The Daily Biotech Pulse: Merck's Keytruda Clinches Another FDA Win, KemPharm Close To NDA Filing For ADHD Drug"
2019-04-11,Viveve Announces CE Mark Clearance for its Next Generation 2.0 Platform in the European Union
2019-03-20,"VIVE: Warning Letter Headwinds Persist, Although Dissipating. 2019 Guidance Implies Much-Improved Operating Loss"
2019-03-19,Edited Transcript of VIVE earnings conference call or presentation 14-Mar-19 9:00pm GMT
2019-03-15,"Viveve Medical Inc (VIVE) Files 10-K for the Fiscal Year Ended on December 31, 2018"
2019-03-14,Viveve Reports Fourth Quarter and Full Year 2018 Financial Results
2019-03-14,"The Daily Biotech Pulse: Arsanis Completes X4 Merger, EC Nod For Roche, Axovant Offering"
2019-03-11,Viveve Completes Enrollment in VIVEVE II Trial
2019-03-07,"Viveve to Host Conference Call to Discuss Fourth Quarter and Year-end 2018 Financial Results and Corporate Update on March 14, 2019"
2019-03-05,Viveve to Present at Cowen and Company 39th Annual Health Care Conference
2019-01-21,"VIVE: Q4 Preannouncement, 2019 Guidance / Strategic Restructuring"
2019-01-16,"Viveve Reports Preliminary Full Year 2018 Financial Results, Announces 2019 Revenue Guidance and Provides Corporate Update"
2019-01-03,Viveve Completes Enrollment in LIBERATE-International Trial for Improvement of Stress Urinary Incontinence
2018-12-24,VIVE: 12-Month SUI Feasibility Study Data Further Supports Compelling Efficacy Signal
2018-12-20,Viveve Announces FDA Clearance to Advance VIVEVE II Clinical Study to Full Enrollment
2018-12-11,Viveve Announces Closing of Public Offering of Shares of Common Stock
2018-12-06,Viveve Announces Pricing of Public Offering of Shares of Common Stock
2018-12-06,Viveve Announces Positive 12-Month Data from Stress Urinary Incontinence Feasibility Study
2018-12-06,Viveve Announces Proposed Public Offering of Shares of Common Stock
2018-11-29,Viveve to Host Stress Urinary Incontinence Symposium with Physician Opinion Leaders
2018-11-26,VIVE: Short-Term Headwinds Result in Lowered Guidance. Clinical Progress Sets Up Several Upcoming Milestones
2018-11-21,"New Research Coverage Highlights Chuy's, Viveve Medical, ClearSign Combustion, WhiteHorse Finance, Crinetics Pharmaceuticals, and Boston Omaha  Consolidated Revenues, Company Growth, and Expectations for 2018"
2018-11-20,Edited Transcript of VIVE earnings conference call or presentation 9-Nov-18 1:00pm GMT
2018-11-16,9 Colorado companies make Deloittes list of fastest-growing tech companies
2018-11-15,Viveve Named One of North Americas 500 Fastest Growing Companies by Deloitte
